Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Vaccine - Page 66

Vaccine

Cellular pertussis vaccine combined with adult formulation of tetanus and diphtheria licensed in persons 10-18 years of age
Life Science History | Vaccine

Cellular pertussis vaccine combined with adult formulation of tetanus and diphtheria licensed in persons 10-18 years of age

On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…

Read More Cellular pertussis vaccine combined with adult formulation of tetanus and diphtheria licensed in persons 10-18 years of ageContinue

Sanofi Pasteur announced FDA approval of Menactra meningococcal conjugate vaccine indication for infants
Diagnostics | FDA | Infectious Disease | Therapeutics | Vaccine

Sanofi Pasteur announced FDA approval of Menactra meningococcal conjugate vaccine indication for infants

On Apr. 22, 2005, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had granted licensure to…

Read More Sanofi Pasteur announced FDA approval of Menactra meningococcal conjugate vaccine indication for infantsContinue

50th anniversary of the Salk Polio vaccine
Polio | Vaccine

50th anniversary of the Salk Polio vaccine

On Apr. 12, 2005 marked the 50th anniversary of the announcement that the polio vaccine, developed by Jonas…

Read More 50th anniversary of the Salk Polio vaccineContinue

HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
Biotechnology | Infectious Disease | Influenza | NIH | Vaccine

HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.

On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department  of…

Read More HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.Continue

The first meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Menactra by Sanofi Pasteur) was licensed
Biotechnology | Vaccine

The first meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Menactra by Sanofi Pasteur) was licensed

On Jan. 14, 2005, the first meningococcal polysaccharide (Serogroups A, C, Y and W-135) diphtheria toxoid conjugate vaccine…

Read More The first meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Menactra by Sanofi Pasteur) was licensedContinue

OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
Biotechnology | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine

OHSU was awarded $4 million NIH biodefense contract to study tuberculosis

On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…

Read More OHSU was awarded $4 million NIH biodefense contract to study tuberculosisContinue

OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
Biotechnology | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine

OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses

On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…

Read More OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox virusesContinue

A significant shortage of influenza vaccine occurred in the U.S.
Biotechnology | Diagnostics | FDA | Infectious Disease | Influenza | Vaccine

A significant shortage of influenza vaccine occurred in the U.S.

On Aug. 25, 2004, a significant shortage of influenza vaccine occurred in the U.S. as a result of…

Read More A significant shortage of influenza vaccine occurred in the U.S.Continue

The 8th and final report of the Immunization Safety Review Committee was issued by the Institute of Medicine
Biotechnology | Medicine | Non-Profit Research | Therapeutics | Vaccine

The 8th and final report of the Immunization Safety Review Committee was issued by the Institute of Medicine

On Jun. 26, 2004, the 8th and final report of the Immunization Safety Review Committee was issued by…

Read More The 8th and final report of the Immunization Safety Review Committee was issued by the Institute of MedicineContinue

Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus
Biotechnology | Influenza | Vaccine

Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virus

On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…

Read More Contracts awarded to Aventis Pasteur and Chiron to develop vaccine against H5N1 avian influenza virusContinue

OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
Biotechnology | HIV | Infectious Disease | NIH | Non-Profit Research | Vaccine

OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine

On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…

Read More OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccineContinue

NIAID awarded a new license agreement for RotaShield, an oral rotavirus vaccine
Biotechnology | NIH | Vaccine

NIAID awarded a new license agreement for RotaShield, an oral rotavirus vaccine

On May 4, 2004, the National Institute of Allergy and Infectious Diseases (NIAID), awarded a new license agreement…

Read More NIAID awarded a new license agreement for RotaShield, an oral rotavirus vaccineContinue

Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensed
Biotechnology | FDA | Infectious Disease | Vaccine

Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensed

On Mar. 24, 2004, the U.S. Food and Drug Administration (FDA) licensed tetanus and diphtheria toxoids adsorbed for…

Read More Tetanus and diphtheria toxoids adsorbed for adult use, preservative-free, was licensedContinue

The National incident Management System was established to coordinate response for public health incidents
Biotechnology | Diagnostics | Infectious Disease | Therapeutics | Vaccine

The National incident Management System was established to coordinate response for public health incidents

On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…

Read More The National incident Management System was established to coordinate response for public health incidentsContinue

Rubella was declared eliminated in the U.S.
Biotechnology | Measles | Vaccine

Rubella was declared eliminated in the U.S.

In 2004, Rubella, also known as German measles, was declared eliminated in the U.S. Before the rubella vaccination…

Read More Rubella was declared eliminated in the U.S.Continue

The University of Georgia Cancer Center was established
Biotechnology | Diagnostics | Medical Device | Non-Profit Research | Therapeutics | Vaccine

The University of Georgia Cancer Center was established

In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…

Read More The University of Georgia Cancer Center was establishedContinue

ACIP voted to recommend influenza vaccination for children aged 6 to 23 months
Biotechnology | CDC | Influenza | Non-Profit Research | Vaccine

ACIP voted to recommend influenza vaccination for children aged 6 to 23 months

On Oct. 15, 2003, the Immunization Practices Advisory Committee (ACIP) voted to recommend that children 6 to 23…

Read More ACIP voted to recommend influenza vaccination for children aged 6 to 23 monthsContinue

$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines
Biotechnology | HIV | Infectious Disease | NIH | Vaccine

$81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccines

On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…

Read More $81 million was awarded by NIAID through four new contracts to support development of candidate HIV vaccinesContinue

OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreak
Biotechnology | Disease | Non-Profit Research | Therapeutics | Vaccine

OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreak

On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…

Read More OHSU announced results of a smallpox vaccine study on America’s preparedness for a smallpox outbreakContinue

The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Therapeutics | Vaccine

The CDC responded to U.S. outbreak of mpox, first human Mpox outside of Africa

On Jul. 8, 2003, the U.S. Centers for Disease Control and Prevention (CDC) responded to U.S. outbreak of…

Read More The CDC responded to U.S. outbreak of mpox, first human Mpox outside of AfricaContinue

The first nasally administered influenza vaccine (FluMist by MedImmune) was licensed
Biotechnology | Influenza | Vaccine

The first nasally administered influenza vaccine (FluMist by MedImmune) was licensed

On Jun. 17, 2003, the first nasally administered influenza vaccine (FluMist by MedImmune) was licensed. This live influenza…

Read More The first nasally administered influenza vaccine (FluMist by MedImmune) was licensedContinue

Michael Smith Genome Science Centre sequenced the SARS genome
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine

Michael Smith Genome Science Centre sequenced the SARS genome

On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…

Read More Michael Smith Genome Science Centre sequenced the SARS genomeContinue

Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
Biotechnology | HIV | Therapeutics | Vaccine

Phase III results for first HIV/AIDS (Aidsvax) vaccine reported

On February 24 2003, VaxGen announced that AIDSVAX B/B did not prove effective in the trials conducted in…

Read More Phase III results for first HIV/AIDS (Aidsvax) vaccine reportedContinue

U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established
Biotechnology | Disease | HIV | Vaccine

U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was established

On Jan. 26, 2003, President Bush, in his State of the Union Address, announced the Emergency Plan for…

Read More U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) was establishedContinue

Public health officials were concerned about re-emergence of H5N1 avian influenza
Biotechnology | Diagnostics | Infectious Disease | Influenza | Vaccine

Public health officials were concerned about re-emergence of H5N1 avian influenza

In 2003, public health officials reported the re-emergence of H5N1 avian influenza for the first time since an…

Read More Public health officials were concerned about re-emergence of H5N1 avian influenzaContinue

Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed
FDA | Infectious Disease | Polio | Vaccine

Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensed

On Dec. 13, 2002, the U.S. Food and Drug Administration (FDA) announced it had licensed a combined diphtheria…

Read More Vaccine that combined diphtheria, tetanus, acellular pertussis, inactivated polio and hepatitis B antigens was licensedContinue

President Bush announced a major smallpox vaccination program
Biotechnology | Infectious Disease | Vaccine

President Bush announced a major smallpox vaccination program

On Dec. 13, 2002, President Bush announced a major smallpox vaccination program to protect the nation against the…

Read More President Bush announced a major smallpox vaccination programContinue

NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune response
Life Science History | Vaccine

NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune response

On Oct. 31, 2002, National Cancer Institute (NCI) researchers announced they had discovered that a molecule best known…

Read More NCI researchers discovered a molecule called Beta-defensin 2 that activates an immune responseContinue

The European Region was certified polio-free
Diagnostics | Infectious Disease | Polio | Vaccine | WHO

The European Region was certified polio-free

On Jun. 21, 2002, all 53 Member States in the World Health Organization (WHO) European Region were certified…

Read More The European Region was certified polio-freeContinue

Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed
FDA | Infectious Disease | Vaccine

Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensed

On May 14, 2002, the Food and Drug Administration (FDA) approved for use an additional combined diphtheria and…

Read More Diphtheria and tetanus toxoids and acellular pertussis vaccine (Daptacel by Aventis Pasteur) was licensedContinue

Page navigation

Previous PagePrevious 1 … 64 65 66 67 68 … 75 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search